K201933

Substantially Equivalent

ImagenSPECT 3.0

Applicant: Cardiovascular Imaging Technologies
Product code: KPS
Advisory panel: Radiology
Date received: 2020-07-13
Decision date: 2020-08-11
Decision: Substantially Equivalent
Clearance type: Special
Location: Kansas City, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.